Orbitofrontal cortex abnormality and deficit schizophrenia

Schizophrenia Research

Volumn 143, Issue 2-3, 2013, Pages 246-252

  Kanahara, Nobuhisa ^a   Sekine, Yoshimoto ^a   Haraguchi, Tadashi ^a   Uchida, Yoshitaka ^b   Hashimoto, Kenji ^a   Shimizu, Eiji ^a   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hypofrontality; Negative symptom; Orbitofrontal gyrus; SPECT

Indexed keywords

ARIPIPRAZOLE; CHLORPROMAZINE; HALOPERIDOL; OLANZAPINE; PEROSPIRONE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN DAMAGE; BRAIN FUNCTION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; NONDEFICIT SYNDROME; ORBITAL CORTEX; OUTCOME ASSESSMENT; PERFUSION; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VOXEL BASED MORPHOMETRY;

ADOLESCENT; ADULT; BRIEF PSYCHIATRIC RATING SCALE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; SCHIZOPHRENIA; SYNDROME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 84872379017     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.11.015     Document Type: Article

References (45)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Press, Washington, DC. 4th ed.
2. Ashton L., Barnes A., Livingston M., Wyper D. Cingulate abnormalities associated with PANSS negative scores in first episode schizophrenia. Behav. Neurol. 2000, 12:93-101. Scottish Schizophrenia Research Group.
3. Buchanan R.W., Breier A., Kirkpatrick B., Elkashef A., Munson R.C., Gellad F., Carpenter W.T. Structural abnormalities in deficit vs non-deficit schizophrenia. Am. J. Psychiatry 1993, 150:59-65.
4. Buchsbaum M.S., Haznedar M.M., Aronowitz J., Brickman A.M., Newmark R.E., Bloom R., Brand J., Goldstein K.E., Heath D., Starson M., Hazlett E.A. FDG-PET in never-previously medicated psychotic adolescents treated with olanzapine or haloperidol. Schizophr. Res. 2007, 94:293-305.
5. Carpenter W.T., Kirkpatrick B. The heterogeneity of the long-term course of schizophrenia. Schizophr. Bull. 1988, 14:645-652.
6. Carpenter W.T., Heinrichs D.W., Wagman A.M. Deficit and nondeficit forms of schizophrenia: the concept. Am. J. Psychiatry 1988, 145:578-583.
7. Cascella N.G., Fieldstone S.C., Rao V.A., Pearlson G.D., Sawa A., Schretlen D.J. Gray-matter abnormalities in deficit schizophrenia. Schizophr Res. 2010, 120:63-70.
8. Cohen A.S., Saperstein A.M., Gold J.M., Kirkpatrick B., Carpenter W.T., Buchanan R.W. Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr. Bull. 2007, 33:1201-1212.
9. Cohen A.S., Brown L.A., Minor K.S. The psychiatric symptomatology of deficit schizophrenia: a meta-analysis. Schizophr. Res. 2010, 118:122-127.
10. Davidson L.L., Heinrichs R.W. Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Res. 2003, 122(2):69-87.
11. Erkwoh R., Sabri O., Steinmeyer E.M., Bull U., Sass H. Psychopathological and SPECT findings in never-treated schizophrenia. Acta Psychiatr. Scand. 1997, 96(1):51-57.
12. Fenton W.S., McGlashan T.H., Victor B.J. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. Am. J. Psychiatry 1994, 151:351-356.
13. Galderisi S., Quarantelli M., Volpe U., Mucci A., Cassano G.B., Invernizzi G., Rossi A., Vita A., Pini S., Cassano P. Patterns of structural MRI abnormalities in deficit and non-deficit schizophrenia. Schizophr. Bull. 2008, 34:393-401.
14. Gonul A.S., Kula M., Esel E., Tutus A., Sofuoglu S. A Tc-99m HMPAO SPECT study of regional cerebral blood flow in drug-free schizophrenic patients with deficit and non-deficit syndrome. Psychiatry Res. Neuroimaging 2003, 123:199-205.
15. Hill K., Mann L., Laws K.R., Stephenson C.M., Nimmo-Smith I., McKenna P.J. Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatr. Scand. 2004, 110(4):243-256.
16. Hornak J., Bramham J., Rolls E.T., Morris R.G., O'Doherty J., Bullock P.R. Changes in emotion after circumscribed surgical lesions of the orbitofrontal and cingulate cortices. Brain 2003, 126:1671-1712.
17. Inada T. DIEPSS: A Second-generation Rating Scale for Antipsychotic-induced Extrapyramidal Symptoms: Drug-induced Extrapyramidal Symptoms Scale 2009, Seiwa Shoten Publishers, Inc., Tokyo.
18. Kanahara N., Shimizu E., Sekine Y., Uchida Y., Shibuya T., Yamanaka H., Hashimoto T., Asaka T., Sasaki T., Miyatake R., Ohkami T., Fukami G., Fujisaki M., Watanabe H., Shirayama Y., Hayashi H., Hashimoto K., Asano M., Iyo M. Does hypofrontality expand to global brain area in progression of schizophrenia?: a cross-sectional study between first-episode and chronic schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:410-415.
19. Kaneda Y., Ohmori T., Addington D. The Japanese version of the Calgary Depression Scale for Schizophrenics (JCDSS). No To Shinkei. 2000, 52(2):163-166.
20. Kim J.J., Mohamed S., Andreasen N.C., O'Leary D.S., Watkins G.L., Boles Ponto L.L., Hichwa R.D. Regional neural dysfunction in chronic schizophrenia studied with positron emission tomography. Am. J. Psychiatry 2000, 157:542-548.
21. Kirkpatrick B., Buchanan R.W., McKenney P.D., Alphs L.D., Carpenter W.T. The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatr. Res. 1989, 30:119-123.
22. Kirkpatrick B., Buchanan R.W., Breier A., Carpenter W.T. Case identification and stability of the deficit syndrome of schizophrenia. Psychiatr. Res. 1993, 47:47-56.
23. Kopelowicz A., Zarate R., Tripodis K., Gonzalez V., Mintz J. Differential efficacy of olanzapine for deficit and nondeficit negative symptoms in schizophrenia. Am. J. Psychiatry 2000, 157:987-993.
24. Kringelbach M.L. The human orbitofrontal cortex: linking reward to hedonic experience. Nat. Rev. Neurosci. 2005, 6:691-702.
25. Kringelbach M.L., Rolls E.T. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog. Neurobiol. 2004, 72:341-372.
26. Liddle P.F., Friston K.J., Frith C.D., Hirsch S.R., Jones T., Frackowiak R.S. Patterns of cerebral blood flow in schizophrenia. Br. J. Psychiatry 1992, 160:179-186.
27. Marshall M., Lewis S., Lockwood A., Drake R., Jones P., Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients. Arch. Gen. Psychiatry 2005, 62:975-983.
28. Miller D.D., Andreasen N.C., O'Leary D.S., Watkins G.L., Ponto L.L.B., Hichwa R.D. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biol. Psychiatry 2001, 49:704-715.
29. Min S.K., An S.K., Jon D.I., Lee J.D. Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naive schizophrenic patients: a high-resolution SPECT study. Psychiatry Res. 1999, 90(3):159-168.
30. Molina V., Sanz J., Reig S., Martínez R., Sarramea F., Luque R., Benito C., Gispert J.D., Pascau J., Desco M. Hypofrontality in men with first-episode psychosis. Br. J. Psychiatry 2005, 186:203-208.
31. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
32. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale. Psychol. Rep. 1964, 10:799-812.
33. Quarantelli M., Larobina M., Volpe U., Amati G., Tedeschi E., Ciarmiello A., Brunetti A., Galderisi S., Alfano B. Stereotaxy-based regional brain volumetry applied to segmented MRI: validation and results in deficit and non-deficit schizophrenia. NeuroImage 2002, 17:373-384.
34. Rolls E.T., Baylis L.L. Gustatory, olfactory, and visual convergence within the primate orbitofrontal cortex. J. Neurosci. 1994, 14:5437-5452.
35. Roth R.M., Flashman L.A., Saykin A.J., McAllister T.W., Vidaver R. Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits. Am. J. Psychiatry 2004, 161:157-159.
36. Schröder J., Buchsbaum M.S., Siegel B.V., Geider F.J., Lohr J., Tang C., Wu J., Potkin S.G. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr. Res. 1996, 19(1):41-53.
37. Semkovska M., Bédard M.A., Stip E. Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives. Encephale 2001, 27:405-415.
38. Strauss G.P., Harrow M., Grossman L.S., Rosen C. Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study. Schizophr. Bull. 2010, 36:788-799.
39. Tamminga C.A., Thaker G.K., Buchanan R., Kirkpatrick B., Alphs L.D., Chase T.N., Carpenter W.T. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch. Gen. Psychiatry 1992, 49:522-530.
40. Tandon R., Nasrallah H.A., Keshavan M.S. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr. Res. 2009, 110:1-23.
41. Turetsky B., Cowell P.E., Gur R.C., Grossman R.I., Shtasel D.E., Gur R.E. Frontal and temporal lobe brain volumes in schizophrenia. Arch. Gen. Psychiatry 1995, 52:1061-1070.
42. Vaiva G., Cottencin O., Llorca P.M., Devos P., Dupont S., Mazas O., Rascle C., Thomas P., Steinling M., Goudemand M. Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002, 26:481-485.
43. Vita A., Bressi S., Perani D., Invernizzi G., Giobbio G.M., Dieci M., Garbarini M., Del Sole A., Fazio F. High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients. Am. J. Psychiatry 1995, 152(6):876-882.
44. Wechsler D. WAIS-R Manual 1981, The Psychological Corporation, New York.
45. Wolkin A., Sanfilipo M., Wolf A.P., Angrist B., Brodie J.D., Rotrosen J. Negative symptoms and hypofrontality in chronic schizophrenia. Arch. Gen. Psychiatry 1992, 49(12):959-965.